{"entity":{"type":"insider","cik":"0001458494","url":"/insider/0001458494","json_url":"/insider/0001458494.json","name":"Vaishnaw Akshay","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":116,"n_filings":35,"first":"2012-07-18","last":"2026-04-20","span_basis":"filed_date"},"name_variants":[{"name":"Vaishnaw Akshay","source":"filing","n_filings":35,"first_seen":"2012-07-18","last_seen":"2026-04-20"}],"transactions":[{"id":6071246,"accession":"0001104659-26-045583","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-045583","line_url":"/filing/0001104659-26-045583#line-1","is_derivative":false,"issuer_cik":"0001458494","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001458494","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Director, Officer (President of R&D)","officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12246.0,"shares_display":"12,246","price_per_share":49.5745,"price_display":"49.57","price_state":"stated","total_value":607089.327,"total_display":"607,089.33","shares_owned_after":630542.0,"shares_owned_after_display":"630,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-16","filed_date":"2026-04-20","scope":"insider"},{"id":5992920,"accession":"0001104659-26-004222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-004222","line_url":"/filing/0001104659-26-004222#line-1","is_derivative":false,"issuer_cik":"0001458494","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001458494","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Director, Officer (President of R&D)","officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20438.0,"shares_display":"20,438","price_per_share":42.7,"price_display":"42.70","price_state":"stated","total_value":872702.6,"total_display":"872,702.60","shares_owned_after":595767.0,"shares_owned_after_display":"595,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider"},{"id":4501114,"accession":"0001415889-25-015001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-015001","line_url":"/filing/0001415889-25-015001#line-2","is_derivative":false,"issuer_cik":"0001458494","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001458494","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Director, Officer (President of R&D)","officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5130.0,"shares_display":"5,130","price_per_share":29.6297,"price_display":"29.63","price_state":"stated","total_value":152000.361,"total_display":"152,000.36","shares_owned_after":617825.0,"shares_owned_after_display":"617,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-29","filed_date":"2025-05-30","scope":"insider"},{"id":4501111,"accession":"0001415889-25-015001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-015001","line_url":"/filing/0001415889-25-015001#line-1","is_derivative":false,"issuer_cik":"0001458494","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001458494","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Director, Officer (President of R&D)","officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1620.0,"shares_display":"1,620","price_per_share":30.0072,"price_display":"30.01","price_state":"stated","total_value":48611.664,"total_display":"48,611.66","shares_owned_after":616205.0,"shares_owned_after_display":"616,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-29","filed_date":"2025-05-30","scope":"insider"},{"id":8757491,"accession":"0001735276-23-000076","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-23-000076","line_url":"/filing/0001735276-23-000076#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1869.0,"shares_display":"1,869","price_per_share":185.54,"price_display":"185.54","price_state":"stated","total_value":346774.26,"total_display":"346,774.26","shares_owned_after":24191.0,"shares_owned_after_display":"24,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-07","scope":"insider"},{"id":8757488,"accession":"0001735276-23-000076","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-23-000076","line_url":"/filing/0001735276-23-000076#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1107.0,"shares_display":"1,107","price_per_share":186.39,"price_display":"186.39","price_state":"stated","total_value":206333.73,"total_display":"206,333.73","shares_owned_after":23084.0,"shares_owned_after_display":"23,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-07","scope":"insider"},{"id":8757485,"accession":"0001735276-23-000076","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-23-000076","line_url":"/filing/0001735276-23-000076#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":771.0,"shares_display":"771","price_per_share":184.7,"price_display":"184.70","price_state":"stated","total_value":142403.7,"total_display":"142,403.70","shares_owned_after":26060.0,"shares_owned_after_display":"26,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-07","scope":"insider"},{"id":8757482,"accession":"0001735276-23-000076","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-23-000076","line_url":"/filing/0001735276-23-000076#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":192.0,"shares_display":"192","price_per_share":189.31,"price_display":"189.31","price_state":"stated","total_value":36347.52,"total_display":"36,347.52","shares_owned_after":22774.0,"shares_owned_after_display":"22,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-07","scope":"insider"},{"id":8757478,"accession":"0001735276-23-000076","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-23-000076","line_url":"/filing/0001735276-23-000076#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101.0,"shares_display":"101","price_per_share":187.37,"price_display":"187.37","price_state":"stated","total_value":18924.37,"total_display":"18,924.37","shares_owned_after":22983.0,"shares_owned_after_display":"22,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-07","scope":"insider"},{"id":8757476,"accession":"0001735276-23-000076","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-23-000076","line_url":"/filing/0001735276-23-000076#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17.0,"shares_display":"17","price_per_share":188.4,"price_display":"188.40","price_state":"stated","total_value":3202.8,"total_display":"3,202.80","shares_owned_after":22966.0,"shares_owned_after_display":"22,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-07","scope":"insider"},{"id":8181857,"accession":"0001735276-23-000045","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-23-000045","line_url":"/filing/0001735276-23-000045#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1013.0,"shares_display":"1,013","price_per_share":194.94,"price_display":"194.94","price_state":"stated","total_value":197474.22,"total_display":"197,474.22","shares_owned_after":18162.0,"shares_owned_after_display":"18,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-27","filed_date":"2023-04-28","scope":"insider"},{"id":8181856,"accession":"0001735276-23-000045","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-23-000045","line_url":"/filing/0001735276-23-000045#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":910.0,"shares_display":"910","price_per_share":193.93,"price_display":"193.93","price_state":"stated","total_value":176476.3,"total_display":"176,476.30","shares_owned_after":19175.0,"shares_owned_after_display":"19,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-27","filed_date":"2023-04-28","scope":"insider"},{"id":8181855,"accession":"0001735276-23-000045","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-23-000045","line_url":"/filing/0001735276-23-000045#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":197.0,"shares_display":"197","price_per_share":193.18,"price_display":"193.18","price_state":"stated","total_value":38056.46,"total_display":"38,056.46","shares_owned_after":20085.0,"shares_owned_after_display":"20,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-27","filed_date":"2023-04-28","scope":"insider"},{"id":8181854,"accession":"0001735276-23-000045","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-23-000045","line_url":"/filing/0001735276-23-000045#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":168.0,"shares_display":"168","price_per_share":197.08,"price_display":"197.08","price_state":"stated","total_value":33109.44,"total_display":"33,109.44","shares_owned_after":17890.0,"shares_owned_after_display":"17,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-27","filed_date":"2023-04-28","scope":"insider"},{"id":8181853,"accession":"0001735276-23-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-23-000045","line_url":"/filing/0001735276-23-000045#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104.0,"shares_display":"104","price_per_share":195.65,"price_display":"195.65","price_state":"stated","total_value":20347.6,"total_display":"20,347.60","shares_owned_after":18058.0,"shares_owned_after_display":"18,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-27","filed_date":"2023-04-28","scope":"insider"},{"id":7852038,"accession":"0001735276-23-000009","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-23-000009","line_url":"/filing/0001735276-23-000009#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19447.0,"shares_display":"19,447","price_per_share":216.38,"price_display":"216.38","price_state":"stated","total_value":4207941.86,"total_display":"4,207,941.86","shares_owned_after":19272.0,"shares_owned_after_display":"19,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-14","scope":"insider"},{"id":7852035,"accession":"0001735276-23-000009","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-23-000009","line_url":"/filing/0001735276-23-000009#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10279.0,"shares_display":"10,279","price_per_share":215.59,"price_display":"215.59","price_state":"stated","total_value":2216049.61,"total_display":"2,216,049.61","shares_owned_after":38719.0,"shares_owned_after_display":"38,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-14","scope":"insider"},{"id":7852032,"accession":"0001735276-23-000009","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-23-000009","line_url":"/filing/0001735276-23-000009#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4302.0,"shares_display":"4,302","price_per_share":217.05,"price_display":"217.05","price_state":"stated","total_value":933749.1,"total_display":"933,749.10","shares_owned_after":14970.0,"shares_owned_after_display":"14,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-14","scope":"insider"},{"id":7852030,"accession":"0001735276-23-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-23-000009","line_url":"/filing/0001735276-23-000009#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2307.0,"shares_display":"2,307","price_per_share":214.28,"price_display":"214.28","price_state":"stated","total_value":494343.96,"total_display":"494,343.96","shares_owned_after":48998.0,"shares_owned_after_display":"48,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-14","scope":"insider"},{"id":7852027,"accession":"0001735276-23-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-23-000009","line_url":"/filing/0001735276-23-000009#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1709.0,"shares_display":"1,709","price_per_share":213.13,"price_display":"213.13","price_state":"stated","total_value":364239.17,"total_display":"364,239.17","shares_owned_after":51305.0,"shares_owned_after_display":"51,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-14","scope":"insider"},{"id":4703507,"accession":"0001735276-21-000097","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-21","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":191.45,"price_display":"191.45","price_state":"stated","total_value":191450.0,"total_display":"191,450.00","shares_owned_after":11862.0,"shares_owned_after_display":"11,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703503,"accession":"0001735276-21-000097","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-20","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":303.0,"shares_display":"303","price_per_share":195.11,"price_display":"195.11","price_state":"stated","total_value":59118.33,"total_display":"59,118.33","shares_owned_after":11215.0,"shares_owned_after_display":"11,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703501,"accession":"0001735276-21-000097","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-19","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":145.0,"shares_display":"145","price_per_share":193.67,"price_display":"193.67","price_state":"stated","total_value":28082.15,"total_display":"28,082.15","shares_owned_after":11518.0,"shares_owned_after_display":"11,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703497,"accession":"0001735276-21-000097","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-18","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144.0,"shares_display":"144","price_per_share":190.02,"price_display":"190.02","price_state":"stated","total_value":27362.88,"total_display":"27,362.88","shares_owned_after":13207.0,"shares_owned_after_display":"13,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703493,"accession":"0001735276-21-000097","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-17","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144.0,"shares_display":"144","price_per_share":189.24,"price_display":"189.24","price_state":"stated","total_value":27250.56,"total_display":"27,250.56","shares_owned_after":13351.0,"shares_owned_after_display":"13,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703490,"accession":"0001735276-21-000097","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-16","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":142.0,"shares_display":"142","price_per_share":190.39,"price_display":"190.39","price_state":"stated","total_value":27035.38,"total_display":"27,035.38","shares_owned_after":12987.0,"shares_owned_after_display":"12,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703487,"accession":"0001735276-21-000097","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-15","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":137.0,"shares_display":"137","price_per_share":187.08,"price_display":"187.08","price_state":"stated","total_value":25629.96,"total_display":"25,629.96","shares_owned_after":13833.0,"shares_owned_after_display":"13,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703484,"accession":"0001735276-21-000097","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-14","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130.0,"shares_display":"130","price_per_share":187.35,"price_display":"187.35","price_state":"stated","total_value":24355.5,"total_display":"24,355.50","shares_owned_after":13703.0,"shares_owned_after_display":"13,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703482,"accession":"0001735276-21-000097","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-13","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":127.0,"shares_display":"127","price_per_share":188.26,"price_display":"188.26","price_state":"stated","total_value":23909.02,"total_display":"23,909.02","shares_owned_after":13576.0,"shares_owned_after_display":"13,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703479,"accession":"0001735276-21-000097","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-12","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126.0,"shares_display":"126","price_per_share":193.37,"price_display":"193.37","price_state":"stated","total_value":24364.62,"total_display":"24,364.62","shares_owned_after":11663.0,"shares_owned_after_display":"11,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703475,"accession":"0001735276-21-000097","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125.0,"shares_display":"125","price_per_share":190.86,"price_display":"190.86","price_state":"stated","total_value":23857.5,"total_display":"23,857.50","shares_owned_after":12862.0,"shares_owned_after_display":"12,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703472,"accession":"0001735276-21-000097","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124.0,"shares_display":"124","price_per_share":186.22,"price_display":"186.22","price_state":"stated","total_value":23091.28,"total_display":"23,091.28","shares_owned_after":13970.0,"shares_owned_after_display":"13,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703469,"accession":"0001735276-21-000097","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73.0,"shares_display":"73","price_per_share":192.25,"price_display":"192.25","price_state":"stated","total_value":14034.25,"total_display":"14,034.25","shares_owned_after":11789.0,"shares_owned_after_display":"11,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703467,"accession":"0001735276-21-000097","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73.0,"shares_display":"73","price_per_share":190.33,"price_display":"190.33","price_state":"stated","total_value":13894.09,"total_display":"13,894.09","shares_owned_after":13129.0,"shares_owned_after_display":"13,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703464,"accession":"0001735276-21-000097","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73.0,"shares_display":"73","price_per_share":189.01,"price_display":"189.01","price_state":"stated","total_value":13797.73,"total_display":"13,797.73","shares_owned_after":13503.0,"shares_owned_after_display":"13,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703462,"accession":"0001735276-21-000097","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8.0,"shares_display":"8","price_per_share":189.18,"price_display":"189.18","price_state":"stated","total_value":1513.44,"total_display":"1,513.44","shares_owned_after":13495.0,"shares_owned_after_display":"13,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":4703458,"accession":"0001735276-21-000097","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-21-000097","line_url":"/filing/0001735276-21-000097#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5.0,"shares_display":"5","price_per_share":190.27,"price_display":"190.27","price_state":"stated","total_value":951.35,"total_display":"951.35","shares_owned_after":13202.0,"shares_owned_after_display":"13,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":5269023,"accession":"0001735276-21-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-21-000081","line_url":"/filing/0001735276-21-000081#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10834.0,"shares_display":"10,834","price_per_share":200.0,"price_display":"200.00","price_state":"stated","total_value":2166800.0,"total_display":"2,166,800.00","shares_owned_after":11215.0,"shares_owned_after_display":"11,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-11","scope":"insider"},{"id":5232272,"accession":"0001735276-21-000051","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-21-000051","line_url":"/filing/0001735276-21-000051#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14708.0,"shares_display":"14,708","price_per_share":175.0,"price_display":"175.00","price_state":"stated","total_value":2573900.0,"total_display":"2,573,900.00","shares_owned_after":11215.0,"shares_owned_after_display":"11,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-18","filed_date":"2021-06-22","scope":"insider"},{"id":4750082,"accession":"0001735276-21-000041","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-21-000041","line_url":"/filing/0001735276-21-000041#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1892.0,"shares_display":"1,892","price_per_share":136.84,"price_display":"136.84","price_state":"stated","total_value":258901.28,"total_display":"258,901.28","shares_owned_after":14756.0,"shares_owned_after_display":"14,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-21","filed_date":"2021-04-21","scope":"insider"},{"id":4750075,"accession":"0001735276-21-000041","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001735276-21-000041","line_url":"/filing/0001735276-21-000041#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":530.0,"shares_display":"530","price_per_share":137.6,"price_display":"137.60","price_state":"stated","total_value":72928.0,"total_display":"72,928.00","shares_owned_after":14226.0,"shares_owned_after_display":"14,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-21","filed_date":"2021-04-21","scope":"insider"},{"id":4750071,"accession":"0001735276-21-000041","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-21-000041","line_url":"/filing/0001735276-21-000041#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":203.0,"shares_display":"203","price_per_share":135.41,"price_display":"135.41","price_state":"stated","total_value":27488.23,"total_display":"27,488.23","shares_owned_after":16648.0,"shares_owned_after_display":"16,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-21","filed_date":"2021-04-21","scope":"insider"},{"id":4750066,"accession":"0001735276-21-000041","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-21-000041","line_url":"/filing/0001735276-21-000041#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107.0,"shares_display":"107","price_per_share":138.48,"price_display":"138.48","price_state":"stated","total_value":14817.36,"total_display":"14,817.36","shares_owned_after":14119.0,"shares_owned_after_display":"14,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-21","filed_date":"2021-04-21","scope":"insider"},{"id":4750054,"accession":"0001735276-21-000041","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-21-000041","line_url":"/filing/0001735276-21-000041#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1678.0,"shares_display":"1,678","price_per_share":136.76,"price_display":"136.76","price_state":"stated","total_value":229483.28,"total_display":"229,483.28","shares_owned_after":21230.0,"shares_owned_after_display":"21,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-21","scope":"insider"},{"id":4750047,"accession":"0001735276-21-000041","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-21-000041","line_url":"/filing/0001735276-21-000041#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":989.0,"shares_display":"989","price_per_share":137.6,"price_display":"137.60","price_state":"stated","total_value":136086.4,"total_display":"136,086.40","shares_owned_after":20241.0,"shares_owned_after_display":"20,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-21","scope":"insider"},{"id":4750044,"accession":"0001735276-21-000041","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-21-000041","line_url":"/filing/0001735276-21-000041#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":622.0,"shares_display":"622","price_per_share":138.64,"price_display":"138.64","price_state":"stated","total_value":86234.08,"total_display":"86,234.08","shares_owned_after":19619.0,"shares_owned_after_display":"19,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-21","scope":"insider"},{"id":4750039,"accession":"0001735276-21-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-21-000041","line_url":"/filing/0001735276-21-000041#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":140.02,"price_display":"140.02","price_state":"stated","total_value":58388.34,"total_display":"58,388.34","shares_owned_after":19202.0,"shares_owned_after_display":"19,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-21","scope":"insider"},{"id":2044395,"accession":"0001735276-20-000101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-20-000101","line_url":"/filing/0001735276-20-000101#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":971.0,"shares_display":"971","price_per_share":140.0,"price_display":"140.00","price_state":"stated","total_value":135940.0,"total_display":"135,940.00","shares_owned_after":14119.0,"shares_owned_after_display":"14,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-29","filed_date":"2020-10-01","scope":"insider"},{"id":2596211,"accession":"0001735276-20-000064","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-20-000064","line_url":"/filing/0001735276-20-000064#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":334.0,"shares_display":"334","price_per_share":152.22,"price_display":"152.22","price_state":"stated","total_value":50841.48,"total_display":"50,841.48","shares_owned_after":14314.0,"shares_owned_after_display":"14,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-24","scope":"insider"},{"id":2596201,"accession":"0001735276-20-000064","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-20-000064","line_url":"/filing/0001735276-20-000064#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001458494","owner_name":"Vaishnaw Akshay","owner_url":"/insider/0001458494","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":195.0,"shares_display":"195","price_per_share":152.97,"price_display":"152.97","price_state":"stated","total_value":29829.15,"total_display":"29,829.15","shares_owned_after":14119.0,"shares_owned_after_display":"14,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-24","scope":"insider"}],"next_cursor":"2020-06-22|2596201","ledger_fault":false,"count":{"value":116,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":116,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":116},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001727196","name":"Scholar Rock Holding Corp","url":"/issuer/0001727196","role":"Director, Officer (President of R&D)","n_filings":3,"first_seen":"2025-05-30","last_seen":"2026-04-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Officer (President)","n_filings":32,"first_seen":"2012-07-18","last_seen":"2023-08-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001458494","retrieved_at":"2026-08-22T02:28:59+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}